Preliminary studies Imperfect bloodspots – what matters for the screening laboratory? UK Newborn Screening Laboratories Network Alex Lawson* Kate Hall.

Slides:



Advertisements
Similar presentations
Newborn Screening: Because you touch the future everyday.
Advertisements

Day 2 You receive 2 reports on your desk –The first describes the possibility of expanding the states newborn screening panel to include Severe Combined.
Practical Blood Bank Lab Adsorption.
Blood Spot samples Jane Gick Paediatric Metabolic Nurse Specialist Evelina Childrens Hospital Guys & St. Thomas NHS Foundation trust.
Independent Project HCAI 5221 Evaluation of Point of Care Bedside Glucose Monitors for Use in a Specialty & Transplant Hospital Mary A. Weidner, BS, MT(ASCP)
Module 14: Blood Collection and Handling Dried Blood Spot
DBS – Process & Review GHANSHYAM. 3Rs No need to explain…………… GOAL IS ANIMAL SAVING R1 REPLACEMENT R2 REFINEMENT R3 REDUCTION.
Learning Objectives Collect Dried Blood Spots (DBS) for HIV testing
Measuring phenylalanine R Neil Dalton The WellChild Trust Laboratory King’s College, London Evelina Children’s Hospital at Guy’s Hospital NSPKU, Skipton,
Invalid Specimen Study
The Newborn Screening Quality Assurance Program. W. Harry Hannon, Ph.D. Chief, Newborn Screening Branch Centers for Disease Control and Prevention.
Pediatric Diagnosis of HIV-1 Infection Using Dried Blood Spots Chin-Yih Ou, PhD NCHSTP/DHAP Centers for Disease Control and Prevention.
DBS preparation from finger stick blood in Microtainer®
The Effect of Unsatisfactory Specimens on Newborn Screening Lisa Kalman, PhD Newborn Screening Quality Assurance Program, CDC.
Use of dried blood spots (DBS) or dried serum/plasma spots (DSS/DPS) to detect recent HIV-1 seroconversion by the BED-CEIA Bharat Parekh, PhD Centers for.
Vironostika® HIV-1 Plus O Microelisa System
Newborn Screening Translational Research Network Goals of the Hunter Kelly Newborn Screening Program Identify, develop and test the most promising technologies.
Melissa Ewerth Graduate Adapted Physical Education, WCU.
Brad Therrell, PhD – NNSGRC Jana Monaco – ACHDNC (parent advocate) W. Harry Hannon, PhD – NNSGRC (CDC) Don Bailey, PhD – RTI (parent advocate) Alaina Harris,
Unsatisfactory Newborn Screening Specimens: Interpretations, Studies and Current Trends Presenters Dr. John Sherwin-California Health Department Dr. Ken.
Overview of Newborn Screening Laboratory Processes and Quality Management Scott M. Shone, PhD Program Manager New Jersey NBS Laboratory SACHDNC May 11,
Building EID Programs Highlights –Bulk purchase of PCR kits reduces cost – now at around 8 USD per test –Supplying DNA PCR tests – with bundles for DBS.
MLAB 1335 Immunology/Serology Terry Kotrla
Tandem Mass Spectrometry Newborn Screening Quality Assurance and Control Instrument and Method Validation Gary Hoffman Wisconsin Newborn Screening Laboratory.
Paper and Thin Layer Chromatography (TLC) Experiment 4 BCH 333[practical]
National Center for Environmental Health Centers for Disease Control and Prevention Suzanne Cordovado, Ph.D. Team Lead, Molecular Quality Improvement Program.
Simoa Accelerator Laboratory
Evaluation of Viral Clearance Studies
What’s in the news right now related to science???? Flesh eating bacteria.
Quality WHAT IS QUALITY
Bias and Errors. Some Terms Used to Describe Analytical Methods Accuracy Precision LOD RDL LOQ Selectivity Sensitivity Linearity Ruggedness.
Prof. of Clinical Chemistry, Mansoura University.
Chapter 5 Errors In Chemical Analyses Mean, arithmetic mean, and average (x) are synonyms for the quantity obtained by dividing the sum of replicate measurements.
4 WELCOME. 4 Two Significant Stats 70 % 40%
Clinical Lab Dilutions MLT 241 Intro to Clinical Chemistry SLO IX. Calculate mathematical manipulations and problems for basic math, the metric system,
FEEDBACK QUESTIONNAIRE Frequency of samples Sample volume Appropriateness of analyte concentrations Adequacy of the report Website display Usefulness.
Copyright  2003 by Dr. Gallimore, Wright State University Department of Biomedical, Industrial Engineering & Human Factors Engineering Human Factors Research.
· Lecture 31 & 32 : Scope of clinical biochemistry ط Uses of clinical biochemistry tests ط Diagnosis, Prognosis, Screening, Monitoring ط Reporting results.
Module 8: Blood Collection and Handling Dried Blood Spot
Evaluation of the Presage™ ST2 ELISA Jun Lu 1, David G. Grenache 1,2 1 ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT 2 Department.
The Scottish Newborn Screening Laboratory (SNSL) Dr David Aitken Laboratory Director Pregnancy and Newborn Screening Institute of Medical Genetics Yorkhill,
Newborn Screening Translational Research Network Virtual Repository of Dried Blood Spots Supplemental Slides February 16, 2012 Call in Number: (470)
I have no relevant financial relationships with the manufacturers of any commercial products and/or provider of commercial services discussed in this CME.
Department of Bioengineering Buffering Capabilities of Guinea Pig Blood GROUP MB3 Kim Coughlan, Barry Huang, Laura Michelis, Le Truong.
Evaluation of Viral Clearance Studies Mahmood Farshid, Ph.D. Div. Of Hematology OBRR/ CBER/FDA.
BACKGROUND The ERNDIM qualitative acylcarnitine external QA scheme circulates dried blood spots from patients with metabolic disease detectable by acylcarnitine.
International Day of Disabled Persons - prompt slides.
GRAVIMETRIC METHODS. Gravimetric methods of which are based upon the measurment of mass, are of two major types: Precipitation Methods Volatilization.
LECTURE 13 QUALITY ASSURANCE METHOD VALIDATION
lecture 10 blood bank Compatibility Testing
 Routine viral diagnostics: indirect and direct detection of viruses. ◦ Indirect detection: serological tests; ◦ Direct detection:  Viral antigens;
NEWBORN BLOODSPOT - IMPROVING PRACTICE. Screening Tests Offered from 4 th Oct 2010: Phenylketonuria (PKU) Congenital Hypothyroidism (CHT)
Highlights on the monitoring and control of preanalytical variables By Mohamed Osama Ali Assistant lecturer of clinical pathology Faculty of medicine Suez.
Summary of Session I Bill Becker, DO MPH Ohio Department of Health Tandem Mass Spectrometry in Newborn Screening.
Compatibility Testing
Comprised of Blood Agar and CHROMagarTM Orientation using WASPLabTM
Scientific Methodology
Discussion and Conclusions
Paper and Thin Layer Chromatography (TLC)
Uncertainty of measurement – practical relevance and the results of the DBS scheme Prof Jim Bonham Clinical Director Sheffield Children’s NHS FT 1.
Practical Blood Bank Adsorption Lab 8
Practical Blood Bank Adsorption Lab 8
Coagulation Factor Assays
Practical Blood Bank Lab 1 ABO Grouping.
The Effects of antibacterial hand soap on bacteria survivorship
Effect of route of administration (i.v. versus i.p.).
Introduction To Medical Technology
Newborn Screening: Because you touch the future everyday.
Checkpoint kinase 1 is essential for fetal and adult hematopoiesis
What if you use a capillary, small specimen or transmission technique
Presentation transcript:

Preliminary studies Imperfect bloodspots – what matters for the screening laboratory? UK Newborn Screening Laboratories Network Alex Lawson* Kate Hall * Birmingham Heartlands Hospital

Poor Sampling – examples from S&S poster Clotted or Layered Serum Rings Specimen Not Dried Before Mailing Supersaturated No Blood Diluted, Discolored, or Contaminated Scratched or Abraded Quantity Insufficient for Testing Supersaturated Specimen Not Dried Before Mailing

UK Newborn Screening Laboratories Network Preliminary study prompted by discussions about widely differing avoidable repeat request rates for dbs between UK screening laboratories BCH has some of the highest rates and yet pride in high quality of bloodspots received

UK Newborn Screening Laboratories Network Study prompted by emergence of Luminex Cardscan equipment and need for consensus criteria for spot rejection Needed to be a scientific basis rather than using say mean Cardscan data from 40 visually good spots

UK Newborn Screening Laboratories Network What is known to affect measured results Variability of filter paper Peripheral or central punching Haematocrit of blood applied

UK Newborn Screening Laboratories Network Variability of filter paper Noted in 1970s by CDC  blood absorption specifications created Slazyk WE, Phillips DL, Therrell BL Jr, Hannon WH. Effect of lot-to-lot variability in filter paper on the quantification of thyroxin, thyrotropin, and phenylalanine in dried-blood specimens. Clin Chem 1988;34:53-8.

UK Newborn Screening Laboratories Network Punch site and haematocrit Holub M, Tuschl K, Ratschmann R, Strnadová KA, Mühl A, Heinze G, Sperl W, Bodamer OA Influence of hematocrit and localisation of punch in dried blood spots on levels of amino acids and acylcarnitines measured by tandem mass spectrometry Clinica Chimica Acta 373 (2006) 27–31 15 mm spots

UK Newborn Screening Laboratories Network Haematocrit Hill JB and Palmer P Filter Paper Blood Collection and Punching As A Means of Quantification Clin Chem 1969, 15/5; The hematocrit value was found to have an influence on the volume of blood contained in a punched spot.

UK Newborn Screening Laboratories Network Where do we punch? In the centre of a full spot? Using a Multipuncher™ or Panthera ™?

UK Newborn Screening Laboratories Network

Typical first punch positions UK Newborn Screening Laboratories Network

Typical second punch positions UK Newborn Screening Laboratories Network

How do we evaluate quality? Visually New – Luminex Cardscan UK Newborn Screening Laboratories Network

Need to study relevant factors for the UK screening programme: 10mm circle rather than 12.5 or 15 Ahlstrom 226 UK panel of screening tests UK Newborn Screening Laboratories Network

Experimental Design UK Newborn Screening Laboratories Network

Blood from a single donor spiked with 6 analytes measured as part of the NBS programme at 3 concentrations Blood was then either –Spotted onto Perkin Elmer 226 cards in 4 different volumes (10 µL, 20 µL, 50 µL & 75 µL) –n = 20 for each volume at each analyte concentration OR –Manipulated using removal or addition of matched donor plasma to create haematocrits of 30%, 40%, 45%, 50% & 60%. –50 µL blood was then spotted onto Perkin Elmer 226 cards –n = 6 for each haematocrit at each analyte concentration UK Newborn Screening Laboratories Network LevelTSHOctanoyl CarnitineLeucineL-MethionineL-PhenylalanineL-Tyrosine Low (endogenous)NA Medium (laboratory based alert) High (clinical alert level)

UK Newborn Screening Laboratories Network 10 µL20 µL50 µL75 µL Spot Volume & Punch Location (Haematocrit 50%) 30% 40%45%50% Haematocrit (Always 50 µL spot punched in middle) 60%

TSH measured by autoDELFIA™ fluoroimmunoassay (Perkin Elmer C8, leucine, methionine, phenylalanine and tyrosine measured by measured by underivatised tandem mass spectrometry Results compared using one-way ANOVA with post-hoc Tukey test (both experiments) and linear regression (haematocrit) (SPSS) Data displayed as percentage change when compared to a 50 µL centre punch UK Newborn Screening Laboratories Network

10 µL20 µL50 µL75 µL Spot Volume & Punch Location (Haematocrit 50%) 30% 40%45%50% Haematocrit (Always 50 µL spot punched in middle) 60% 50 µL spot punched in middle with haematocrit of 50% used as ‘standard’

Results – Effect of spot size and punch location UK Newborn Screening Laboratories Network

Effect of spot size and punch location on new born screening results: Analytes at low (endogenous) concentrations * = p <0.05 ** p = < n = 20 for each bar. Error bars represent +/- SEM. * ** * * * * * *

UK Newborn Screening Laboratories Network Effect of spot size and punch location on new born screening results: Analytes at medium (lab alert) concentrations * ** * * = p <0.05 ** p = < n = 20 for each bar.* = p <0.05 ** p = < n = 20 for each bar. Error bars represent +/- SEM.

UK Newborn Screening Laboratories Network Effect of spot size and punch location on new born screening results: Analytes at high (clinical alert) concentrations * = p <0.05 ** p = < n = 20 for each bar.* = p <0.05 ** p = < n = 20 for each bar. Error bars represent +/- SEM. * ** *

Results – Effect of haematocrit UK Newborn Screening Laboratories Network

Effect of haematocrit on new born screening results: Analytes at low (endogenous) concentrations * = p <0.05 ** p = < n = 6 for each data point. Error bars represent +/- SEM. Low AnalyteR2R2 p TSHNA C Leu0.398<0.001 Met Phe0.759<0.001 Tyr % 40% 45% 60%

UK Newborn Screening Laboratories Network Effect of spot size and punch location on new born screening results: Analytes at medium (lab alert) concentrations * = p <0.05 ** p = < n = 6 for each data point. Error bars represent +/- SEM. ** * * Medium AnalyteR2R2 p TSH0.815<0.001 C80.661<0.001 Leu Met Phe Tyr % 40% 45% 60%

UK Newborn Screening Laboratories Network Effect of spot size and punch location on new born screening results: Analytes at high (clinical alert) concentrations * = p <0.05 ** p = < n = 6 for each data point. Error bars represent +/- SEM. ** * * High AnalyteR2R2 p TSH0.863<0.001 C80.734<0.001 Leu Met0.581<0.001 Phe0.805<0.001 Tyr0.651< % 40% 45% 60%

UK Newborn Screening Laboratories Network Analyte ‘True’ resultCentre punch Hct 30% Centre punch Hct 60% Centre Punch 10 µL spot TSH C Leu Met Phe Tyr Laboratory alert level

UK Newborn Screening Laboratories Network Analyte ‘True’ resultCentre punch Hct 30% Centre punch Hct 60% Centre Punch 10 µL spot TSH C Leu Met Phe Tyr Clinical alert level

UK Newborn Screening Laboratories Network Age in days

UK Newborn Screening Laboratories Network Age in years

Work with Finlay Mackenzie from UKNEQAS to confirm our preliminary findings and extend haematocrit work Prove that washed red cells with added plasma behaves similarly Extend analytes to include those for expanded nbs UK Collect all Cardscan data on cards in study Determine which Cardscan measurements will signal significant departure from true results UK Newborn Screening Laboratories Network Future plans

Deliberately falsify manufactured bloodspots Evaluate in Cardscan then measure analytes UK Newborn Screening Laboratories Network Later plans